Veracyte Stock Filter Stocks by Fundamentals
| VCYT Stock | USD 23.51 0.71 2.93% |
Veracyte's fundamental analysis aims to assess its intrinsic value by examining key economic and financial indicators - such as cash flow records, changes in balance sheet accounts, income statement trends, financial ratios, and relevant microeconomic factors affecting Veracyte Stock price.
Veracyte | Shares Owned by Institutions | Build AI portfolio with Veracyte Stock |
Veracyte Current Valuation Drivers
We derive many important indicators used in calculating different scores of Veracyte from analyzing Veracyte's financial statements. These drivers represent accounts that assess Veracyte's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Veracyte's important valuation drivers and their relationship over time.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Market Cap | 2.6B | 2.8B | 1.7B | 2.0B | 3.0B | 3.2B | |
| Enterprise Value | 2.3B | 2.6B | 1.6B | 1.8B | 2.8B | 3.0B |
Veracyte ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Veracyte's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Veracyte's managers, analysts, and investors.Environmental | Governance | Social |
Veracyte Institutional Holders
Institutional Holdings refers to the ownership stake in Veracyte that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Veracyte's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Veracyte's value.| Shares | Geode Capital Management, Llc | 2025-03-31 | 1.9 M | Driehaus Capital Management Llc | 2025-03-31 | 1.4 M | Gw&k Investment Management, Llc | 2025-03-31 | 1.3 M | Nuveen Asset Management, Llc | 2024-12-31 | 1.2 M | Bank Of America Corp | 2025-03-31 | 1.2 M | Nuveen, Llc | 2025-03-31 | 1.1 M | Goldman Sachs Group Inc | 2025-03-31 | 1 M | Northern Trust Corp | 2025-03-31 | 1 M | First Trust Advisors L.p. | 2025-03-31 | 1 M | Vanguard Group Inc | 2025-03-31 | 8.3 M | Blackrock Inc | 2025-03-31 | 7.5 M |
Veracyte Fundamentals
| Return On Equity | 0.0286 | ||||
| Return On Asset | 0.0194 | ||||
| Profit Margin | 0.07 % | ||||
| Operating Margin | 0.07 % | ||||
| Current Valuation | 1.66 B | ||||
| Shares Outstanding | 78.31 M | ||||
| Shares Owned By Insiders | 0.54 % | ||||
| Shares Owned By Institutions | 99.46 % | ||||
| Number Of Shares Shorted | 6.16 M | ||||
| Price To Earning | (10.61) X | ||||
| Price To Book | 1.59 X | ||||
| Price To Sales | 3.97 X | ||||
| Revenue | 445.76 M | ||||
| Gross Profit | 326.41 M | ||||
| EBITDA | 49.2 M | ||||
| Net Income | 24.14 M | ||||
| Cash And Equivalents | 170.11 M | ||||
| Cash Per Share | 2.37 X | ||||
| Total Debt | 50.74 M | ||||
| Debt To Equity | 0.02 % | ||||
| Current Ratio | 4.09 X | ||||
| Book Value Per Share | 15.26 X | ||||
| Cash Flow From Operations | 75.1 M | ||||
| Short Ratio | 6.04 X | ||||
| Earnings Per Share | 0.42 X | ||||
| Target Price | 40.89 | ||||
| Number Of Employees | 824 | ||||
| Beta | 2.1 | ||||
| Market Capitalization | 1.84 B | ||||
| Total Asset | 1.3 B | ||||
| Retained Earnings | (443.98 M) | ||||
| Working Capital | 293.63 M | ||||
| Current Asset | 47.91 M | ||||
| Current Liabilities | 14.72 M | ||||
| Net Asset | 1.3 B |
About Veracyte Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Veracyte's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Veracyte using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Veracyte based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Veracyte Stock Analysis
When running Veracyte's price analysis, check to measure Veracyte's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Veracyte is operating at the current time. Most of Veracyte's value examination focuses on studying past and present price action to predict the probability of Veracyte's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Veracyte's price. Additionally, you may evaluate how the addition of Veracyte to your portfolios can decrease your overall portfolio volatility.